Send up to 200 candidate molecules through Phase I, Phase II, Phase III and regulatory review and watch the funnel empty. Set the success rate of every stage, the portfolio size, the stage costs and the discount rate, then read the likelihood of approval, the chance of at least one approval, the candidates needed for a 90 % chance, the cost per approved drug and the risk-adjusted NPV. Blender-built sample vials, stage gates and discard trays, with binomial-thinning, Monte Carlo, bisection and path-enumeration checks built in. Stage success rates follow typical published industry averages and costs are illustrative; this is an educational model, not a forecast for any project.